| Metric | შპს დენკ ფარმა კავკასია | შპს თბილისი მედიკ | შპს ნიუ ფარმა |
|---|---|---|---|
| Growth | |||
| Revenue | ₾22.1m₾20.5m | ₾14.8m₾14.3m | ₾14.6m₾21.9m |
| Revenue growth | 7.7% | 3.5% | -33.2% |
| Profitability | |||
| EBITDA | ₾2.4m₾833k | ₾827k₾1.8m | -₾27k₾3.5m |
| EBITDA margin | 10.7%4.1% | 5.6%12.3% | -0.2%15.8% |
| Net profit | ₾1.4m₾589k | -₾2.2m | |
| -₾1.2m₾2.1m |
| Net margin | 6.4%2.9% | -14.8%13.2% | -8.4%9.7% |
| Balance sheet | |||
| Total assets | ₾13.2m₾11.6m | ₾18.7m₾19.7m | ₾9.7m₾10.9m |
| Total equity | ₾4.6m₾4.7m | ₾14.2m₾16.3m | ₾3.4m₾5.9m |
| ROE | 30.4%12.5% | -15.5%11.6% | -35.4%36.1% |